A model of evaluative opinion to encourage greater transparency and justification of interpretation in postmortem forensic toxicology.


Journal

Journal of analytical toxicology
ISSN: 1945-2403
Titre abrégé: J Anal Toxicol
Pays: England
ID NLM: 7705085

Informations de publication

Date de publication:
15 Sep 2023
Historique:
received: 13 04 2023
revised: 31 07 2023
accepted: 10 08 2023
medline: 18 9 2023
pubmed: 11 8 2023
entrez: 11 8 2023
Statut: ppublish

Résumé

Over the past decades, the calls to improve the robustness of interpretation in forensic science have increased in magnitude. Forensic toxicology has seen limited progress in this regard. In this work, we propose a transparent interpretive pathway for use in postmortem forensic toxicology cases. This process allows the selection of the interpretive methodology based on the amount of previous information that is available for the drug(s) in question. One approach is an assessment of various pharmacological and circumstantial considerations resulting in a toxicological significance score (TSS), which is particularly useful in situations where limited information about a drug is available. When there is a robust amount of case data available, then a probabilistic approach, through the evaluation of likelihood ratios by the forensic toxicologist and of prior probabilities by the fact finder, is utilized. This methodology provides a transparent means of making an interpretive decision on the role of a drug in the cause of death. This will allow the field of forensic toxicology to take a step forward in using best practice in evaluative reporting, a tool already used by many other forensic science disciplines.

Identifiants

pubmed: 37566485
pii: 7241422
doi: 10.1093/jat/bkad055
pmc: PMC10503647
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

563-573

Informations de copyright

© The Author(s) 2023. Published by Oxford University Press.

Références

Addiction. 2020 Aug 1;:
pubmed: 32738014
J Forensic Sci. 2021 Sep;66(5):1751-1757
pubmed: 33608908
J Anal Toxicol. 2015 Mar;39(2):113-7
pubmed: 25414249
J Forensic Sci. 2003 Jul;48(4):874-9
pubmed: 12877310
Am J Forensic Med Pathol. 2020 Sep;41(3):152-159
pubmed: 32404634
Drug Test Anal. 2015 Oct;7(10):926-36
pubmed: 25847502
Forensic Sci Int. 2020 Jun;311:110292
pubmed: 32330811
Clin Chem. 1998 Mar;44(3):622-31
pubmed: 9510871
J Forensic Sci. 1997 Jan;42(1):79-87
pubmed: 8988577
Int J Legal Med. 2022 Jul;136(4):1027-1036
pubmed: 34988615
Arch Toxicol. 2022 Jun;96(6):1865-1880
pubmed: 35449307
J Forensic Leg Med. 2013 Oct;20(7):842-7
pubmed: 24112333
Forensic Sci Int Synerg. 2020 Jun 30;2:339-348
pubmed: 33385132
Med Sci Law. 2021 Apr;61(2):122-129
pubmed: 33236683
Forensic Sci Int. 2017 Dec;281:29-36
pubmed: 29101905
Br J Clin Pharmacol. 2008 Oct;66(4):430-43
pubmed: 18637886
Bull World Health Org Suppl. 1952;3:1-20
pubmed: 14916317
Forensic Sci Int. 2012 Feb 10;215(1-3):18-24
pubmed: 21353406
J Forensic Sci. 2017 May;62(3):832-833
pubmed: 28382691
Drug Test Anal. 2018 Jan;10(1):120-126
pubmed: 28635164

Auteurs

Peter D Maskell (PD)

Scottish Police Authority Forensic Services, Glasgow G69 8AE, UK.
Forensic Medicine and Science, University of Glasgow, Glasgow G12 8QQ, UK.

Simon Elliott (S)

Elliott Forensic Consulting, Birmingham, UK.
Department of Analytical, Environmental and Forensic Sciences, King's College London, London SE1 9NH, UK.

Brigitte Desharnais (B)

Department of Toxicology, Laboratoire de sciences judiciaires et de médecine légale, 1701 Parthenais Street, Montréal, QC H2K 3S7, Canada.

Martin Findell (M)

Division of Psychology and Forensic Science, School of Applied Sciences, Abertay University, Dundee DD1 1HG, UK.

Graham Jackson (G)

Division of Psychology and Forensic Science, School of Applied Sciences, Abertay University, Dundee DD1 1HG, UK.
Advance Forensic Science, St. Andrews, Scotland, UK.

Articles similaires

Humans Female Male Cerebral Amyloid Angiopathy Alzheimer Disease
Humans Male Female Middle Aged Autopsy
Humans Male Death, Sudden, Cardiac Female Japan
1.00
Humans Male Female Aged Amyloidosis

Classifications MeSH